Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 99, Issue 1, Pages 38-48
Publisher
Wiley
Online
2015-10-27
DOI
10.1002/cpt.284
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-4 and IL-13 signaling in allergic airway disease
- (2015) Naina Gour et al. CYTOKINE
- Human metapneumovirus infection activates the TSLP pathway that drives excessive pulmonary inflammation and viral replication in mice
- (2015) Margarita K. Lay et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma
- (2015) Steven G. Smith et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy
- (2015) Jennifer Namazy et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis
- (2015) Hyun-Woo Shin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation
- (2015) L Dejager et al. Mucosal Immunology
- Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
- (2015) Nicola A Hanania et al. THORAX
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
- (2015) Mario Castro et al. Lancet Respiratory Medicine
- Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Christopher E Brightling et al. Lancet Respiratory Medicine
- Epithelial Interleukin-25 Is a Key Mediator in Th2-High, Corticosteroid-Responsive Asthma
- (2014) Dan Cheng et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects
- (2014) J. P. Arm et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma
- (2014) Hea Yon Lee et al. EXPERIMENTAL LUNG RESEARCH
- Thymic stromal lymphopoietin: a central regulator of allergic asthma
- (2014) Brittany Watson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab
- (2014) Aidan Long et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling
- (2014) Jennifer E. Ho et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression and Cellular Provenance of Thymic Stromal Lymphopoietin and Chemokines in Patients with Severe Asthma and Chronic Obstructive Pulmonary Disease
- (2014) S. Ying et al. JOURNAL OF IMMUNOLOGY
- Interleukin (IL)-33: New Therapeutic Target for Atopic Diseases
- (2014) Takeshi Nabe JOURNAL OF PHARMACOLOGICAL SCIENCES
- The alarmin IL-33 promotes regulatory T-cell function in the intestine
- (2014) Chris Schiering et al. NATURE
- Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
- (2014) Gail M. Gauvreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling
- (2014) J. Zhong et al. Database-The Journal of Biological Databases and Curation
- Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
- (2014) Mario Castro et al. Lancet Respiratory Medicine
- Anti-IL5 therapy for asthma and beyond
- (2014) Manali Mukherjee et al. World Allergy Organization Journal
- Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
- (2013) William W. Busse et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An investigation into IgE-facilitated allergen recognition and presentation by human dendritic cells
- (2013) Inas K Sharquie et al. BMC IMMUNOLOGY
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice
- (2013) Nobuaki Mizutani et al. IMMUNOLOGY
- IL-25 and IL-25 Receptor Expression on Eosinophils from Subjects with Allergic Asthma
- (2013) Wei Tang et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
- (2013) Michel Laviolette et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis
- (2013) E. Hams et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma
- (2013) Chad K Oh et al. RESPIRATORY RESEARCH
- Reassessment of Omalizumab-Dosing Strategies and Pharmacodynamics in Inner-City Children and Adolescents
- (2013) Christine A. Sorkness et al. Journal of Allergy and Clinical Immunology-In Practice
- A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
- (2012) Edward Piper et al. EUROPEAN RESPIRATORY JOURNAL
- Eculizumab for treatment of asthma
- (2012) Steven G Smith et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Omalizumab and the risk of malignancy: Results from a pooled analysis
- (2012) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes
- (2012) Florence E. Roufosse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Glucocorticoid Receptor-Beta Up-Regulation and Steroid Resistance Induction by IL-17 and IL-23 Cytokine Stimulation in Peripheral Mononuclear Cells
- (2012) Alejandro Vazquez-Tello et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Periostin promotes chronic allergic inflammation in response to Th2 cytokines
- (2012) Miho Masuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
- (2012) E. Lefrancais et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reslizumab for Poorly Controlled, Eosinophilic Asthma
- (2011) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Silencing IL-23 expression by a small hairpin RNA protects against asthma in mice
- (2011) Yanchun Li et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Benralizumab – a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity – a novel approach for the treatment of asthma
- (2011) Aasia Ghazi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses
- (2011) Chris J. Corrigan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Th9: A New Player in Asthma Pathogenesis?
- (2011) Junchao Xing et al. JOURNAL OF ASTHMA
- Lebrikizumab Treatment in Adults with Asthma
- (2011) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
- (2011) William W. Busse et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma
- (2010) Jonathan Corren et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IL-9 Governs Allergen-induced Mast Cell Numbers in the Lung and Chronic Remodeling of the Airways
- (2010) Jennifer Kearley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma
- (2010) Gail M. Gauvreau et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Induction of glucocorticoid receptor-β expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines
- (2010) A. Vazquez-Tello et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial
- (2010) S. T. Holgate et al. EUROPEAN RESPIRATORY JOURNAL
- IL-33 Mediates Inflammatory Responses in Human Lung Tissue Cells
- (2010) A. Yagami et al. JOURNAL OF IMMUNOLOGY
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
- (2010) Daniel R. Neill et al. NATURE
- Role of IL-23 and Th17 Cells in Airway Inflammation in Asthma
- (2010) Hiroshi Nakajima et al. Immune Network
- After 6âyears with Xolair; a 3-year withdrawal follow-up
- (2009) A. Nopp et al. ALLERGY
- A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma
- (2009) Sally E. Wenzel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma
- (2009) Philip J. Lowe et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Safety and tolerability of omalizumab
- (2009) J. Corren et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations
- (2009) Raymond G. Slavin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- TH17-associated cytokines (IL-17A and IL-17F) in severe asthma
- (2009) Wisam Al-Ramli et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells
- (2009) D. Prefontaine et al. JOURNAL OF IMMUNOLOGY
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
- (2009) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-33 – cytokine of dual function or novel alarmin?
- (2009) Guttorm Haraldsen et al. TRENDS IN IMMUNOLOGY
- IL-23 and Th17 Cells Enhance Th2-Cell–mediated Eosinophilic Airway Inflammation in Mice
- (2008) Hidefumi Wakashin et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started